CCL2 and idiopathic pulmonary fibrosis: Shinoda et al. reported that BALF levels of CCL2 were significantly elevated in IPF patients who did not survive beyond 5 years post-diagnosis compared to those with better prognoses, suggesting that elevated CCL2 predicts poorer outcomes (Shinoda et al., 2009).